Delivery Order SPE2DB25D3012-SPE2DB25FWYBY
- Not listed
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 MG daily dose (60-count supply) on June 18, 2025, with completion targeted for July 11, 2025. This non-set-aside contract represents a direct pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count units) with a contract ceiling value of $10,223.24. This firm fixed price delivery order, which is expected to be completed by September 9, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of LENVIMA 20 mg daily dose tablets (60-count packaging) valued at $10,223.24. This is a firm fixed-price delivery order with no set-aside designation, executed as a competitive award. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of LENVIMA 14 mg daily dose tablets (60-count packaging) with a contract ceiling value of $10,223.24. This competitive award, issued under a firm fixed price delivery order with no set-aside designation, is scheduled for ultimate completion on September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose, 60-count units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 5, 2025. The award was issued on July 15, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20.4K delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 10 mg daily dose tablets (30-count packages) under a firm fixed price contract. The award, issued on August 4, 2025, with completion targeted for August 25, 2025, represents a non-competitive delivery order executed through the company's existing indefinite delivery contract (IDC) framework. Performance will be fulfilled from AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count package) valued at $29,732.85. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose 30-count supply on July 29, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies,...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose tablets (30-count package) on June 30, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lenvima 14 mg daily dose (60-count package), with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYBYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of LENVIMA 8 mg daily dose tablets (60-count) on June 18, 2025, with completion scheduled for July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning AmerisourceBergen as a key pharmaceutical vendor within the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 6/18/25 |